EYETECH PHARMACEUTICALS INC has a total of 14 patent applications. Its first patent ever was published in 2002. It filed its patents most often in WIPO (World Intellectual Property Organization), Argentina and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are ALFACT INNOVATION, LAFRANCESCA SAVERIO and STEMCYTE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Argentina | 2 | |
#3 | Canada | 2 | |
#4 | Brazil | 1 | |
#5 | Chile | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Norway | 1 | |
#9 | Taiwan | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Agriculture |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes | |
#5 | Implantable devices | |
#6 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Adamis Anthony P | 9 |
#2 | Calias Perry | 8 |
#3 | Shima David | 6 |
#4 | Wincott Francine | 5 |
#5 | Shima David T | 4 |
#6 | Guyer David R | 3 |
#7 | Cunningham Ememett T | 1 |
#8 | Breegi Wisam | 1 |
#9 | Clark Paul T | 1 |
#10 | Anthony P Adamis David T Shima | 1 |
Publication | Filing date | Title |
---|---|---|
WO2006055416A2 | Transgenic mouse capable of over-expressing vascular endothelial protein tyrosine phosphatase (ve-ptp) | |
TW200516143A | 5'-and 3'-capped aptamers and uses thereof |